US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Neurizon Therapeutics Ltd (NUZ) 銘柄情報

Neurizon Therapeutics Ltd (NUZ)

0.06

-0.001

(-1.64%)

終了 6月7日 3:00PM

Neurizon Therapeutics Ltd (NUZ) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

0.06

( -1.64% )

買値

0.06

売値

0.062

出来高

975,114

0.06 日の範囲 0.062

0.06 52 週間の範囲 0.185

時価総額

前日終値

0.061

始値

0.061

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 565,535

発行済株式数

746,274,115

配当利回り

PER

-2.2

1 株当たり利益 (EPS)

-0.03

歳入

5.98M

純利益

-14.85M

Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases. The company develops drug discovery intellectual property for the treatment of neurological diseases. Its lead candidate is NUZ-001, a small molecule drug which is in Phase II... Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases. The company develops drug discovery intellectual property for the treatment of neurological diseases. Its lead candidate is NUZ-001, a small molecule drug which is in Phase II clinical trials for the treatment of amyotrophic lateral sclerosis, as well as to treat other neurodegenerative diseases. The company was formerly known as PharmAust Limited and changed its name to Neurizon Therapeutics Limited in October 2024. Neurizon Therapeutics Limited was incorporated in 2000 and is based in Melbourne, Australia. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

www.neurizon.com

本社

Melbourne, Australia

設立

2026

Neurizon Therapeutics Ltd is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker NUZ. The last closing price for Neurizon Therapeutics was AUD0.06. Over the last year, Neurizon Therapeutics shares have traded in a share price range of AUD 0.06 to AUD 0.185.

Neurizon Therapeutics currently has 746,274,115 shares in issue. The market capitalisation of Neurizon Therapeutics is AUD44.78 million. Neurizon Therapeutics has a price to earnings ratio (PE ratio) of -2.20.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.007	-10.447761194	0.067	0.069	0.06	865306	0.06344397	DE
4	-0.018	-23.0769230769	0.078	0.078	0.06	707268	0.06732902	DE
12	-0.033	-35.4838709677	0.093	0.105	0.06	575938	0.07640833	DE
26	-0.045	-42.8571428571	0.105	0.125	0.06	574059	0.08455788	DE
52	-0.09	-60	0.15	0.185	0.06	570208	0.11319823	DE
156	-0.17	-73.9130434783	0.23	0.245	0.06	520061	0.12654513	DE
260	-0.17	-73.9130434783	0.23	0.245	0.06	520061	0.12654513	DE

NUZ - Frequently Asked Questions (FAQ)

What is the current Neurizon Therapeutics Ltd share price?

The current share price of Neurizon Therapeutics Ltd is AUD 0.06

How many Neurizon Therapeutics Ltd shares are in issue?

Neurizon Therapeutics Ltd has 746,274,115 shares in issue

What is the market cap of Neurizon Therapeutics Ltd?

The market capitalisation of Neurizon Therapeutics Ltd is AUD 44.78M

What is the 1 year trading range for Neurizon Therapeutics Ltd share price?

Neurizon Therapeutics Ltd has traded in the range of AUD 0.06 to AUD 0.185 during the past year

What is the PE ratio of Neurizon Therapeutics Ltd?

The price to earnings ratio of Neurizon Therapeutics Ltd is -2.2

What is the cash to sales ratio of Neurizon Therapeutics Ltd?

The cash to sales ratio of Neurizon Therapeutics Ltd is 8.11

What is the registered address of Neurizon Therapeutics Ltd?

The registered address for Neurizon Therapeutics Ltd is Suite 2, Melbourne, Victoria, 3000

What is the Neurizon Therapeutics Ltd website address?

The website address for Neurizon Therapeutics Ltd is www.neurizon.com

Which industry sector does Neurizon Therapeutics Ltd operate in?

Neurizon Therapeutics Ltd operates in the Biotechnology & Life Sciences sector

JamesF1

JamesF1 4分前

HGilS, look at Plavix 75mg before and after patent expiration to get an idea of the change in market size. You might find that jour_traders is not that far off. BTW, I find his posts bullish. He clearly says Eliquis generic is a significant positive for Elite. My guess is there is an M&A announc

trunkmonk

trunkmonk 6分前

oh u made it there years ago from what i gather. very determined, i commend you.

meitze

More like a hit piece. Perhaps unintentional. If it was supposed to inform people about how the Texatron is supposed to work, why all the negative words suggesting it has a long way to go, and is an experiment. Didn't the CEO just say it worked?

Lifetime

Lifetime 9分前

Section 10(b) and Rule 10b-5 of the Securities Exchange Act of 1934

CanItBThisEZ2Make

CanItBThisEZ2Make 11分前

BEST SELLERS RANK (BSR) IS 494 34 Estimated Sold on Amazon Since APRIL 1 - 2ND Quarter 2026
https://investorshub.advfn.com/uimage/uploads/2024/4/24/cnxttVOS_5G_GIF.gif
https://www.amazon.com/Vos-RDGL5GX55-B-01-VOS-5G-Dongle/dp/B0C66KHZLP

NOTE: In theory, when BSR Value D

8lang

This Supreme Court ruling is a major victory for the SEC (Securities and Exchange Commission). Essentially, it means the SEC can still force fraudsters to give back their illegal profits, even if they can't prove a specific investor lost money.
Here is a breakdown of what this means, why it m

rosemountbomber

rosemountbomber 13分前

Shadolane those are key and salient questions you ask. Many investors long ago thought that the single product company that Amarin was/is, had its best future in being acquired. You can say that now probably the vast, vast majority of investors in Amarin finally realize that that is true more than

eastunder

eastunder 14分前

NOW 96.67 gap

https://www.stockscores.com/chart.asp?TickerSymbol=NOW&TimeRange=60&Interval=d&Volume=1&ChartType=CandleStick&Stockscores=None&ChartWidth=1000&ChartHeight=500&LogScale=None&Band=&avgType1=SMA&movAvg1=9&avgType2=SMA&movAvg2=5&Indicator1=None&Indicator2=&Indicator3=&Indica

bobroo

bobroo 14分前

Couple things:

--When someone writes a post or references "news" that contains the words 'liquid metal', they are deliberately trying to deceive you. They want the reader to think or understand they mean our Liquidmetal but if they write it as 'liquid metal' they can always deny accou

eastunder

eastunder 17分前

NOW plan cpps 110.97 Gap 110.16 and 96.67
124.74 gap filled ✔️
83L on Tk 4/10, others 84's and 85's St's
RH?127 -133 on B1st then S31 days if still down (TH)
or Hld and core next year

20d curr 105.15 and 50d 99.06

https://www.stockscores.co

cottonmather

cottonmather 18分前

I've played on the road a couple times with Darell Scott. He is a famous songwriter and one of my favorite people. Here is a recent https://youtu.be/_N2CIVmIcW4?si=32zt5IAYf-umlp2Ishort video

capgain

capgain 21分前

Charlie Starr - Full Performance (30A Songwriters Sessions)

https://www.youtube.com/watch?v=agjjBk1N2n0

Lacey1

Lacey1 23分前

Then what is it Bio? If not to endorce a new line of research that addresses the advancement of treatment from the experts in the field who treat patients daily.

train21

train21 23分前

$SNTX
Leal not trust worthy and nothing verified
bringing more persons in to share the blame is all
share price is steady around a penny for weeks like it was controlled ?
I am out again will go back in at the bottom
good luck to all

juicyjuice10002

juicyjuice10002 24分前

https://www.nytimes.com/2026/06/04/us/politics/supreme-court-sec-disgorgement.html

This Supreme Court ruling is a major victory for the SEC (Securities and Exchange Commission). Essentially, it means the SEC can still force fraudsters to give back their illegal profits, even if they c

spdpro

spdpro 27分前

Emini Barry >
https://youtu.be/bqGR4904Ymo

eastunder

eastunder 28分前

QNT

6-4-26

60.00

6-4-2026 IPO 60.00

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177116335 Quantinuun, Inc. (Nyse: QNT)

https://www.sec.gov/edgar/search/#/ciks=0002110105&entityName=Quantinuum%2520Inc.%2

learningcurve2020

learningcurve2020 29分前

Very predictable you’d all ignore this GBM patient / Hedge fund manager article. I’m sure the disciples are all huddling over on DanishDud’s shiny new site. LOL. Can’t make it up.

https://www.cnbc.com/2026/06/05/warren-buffett-disciple-guy-spiers-rare-cancer-made-him-revalu

Green Leaf Smoker

Green Leaf Smoker 30分前

Well I'll be damn"ed" MJNA goes down! Here's the BEAR link to POS MJNA ....Enough Said
https://investorshub.advfn.com/stock-market/USOTC/medical-marijuana-id-MJNA/trades#google_vignette
.....current Bail Out SP O.OOO1 No Kid wants ones 50% + stock loss 🤣😂🤣

B RY

"Jensen Huang just gave one of the most bullish signals yet for the memory industry $MU $DRAM

$NVDA released 4 new products and at NVIDIA’s Korea event, he repeatedly emphasized one thing: more memory.

• Vera Rubin supercomputers need massive amounts of HBM
• Ve

IhidfromtheX

IhidfromtheX 32分前

Until there's a paradigm shift in the OG's thinking, precision medicine is stalled. The company now is back to its beginnings. Missling failed in proving to the OG that his methodology of small studies is the correct way to judge approving medications. The Anavex drug may or may not be the eye ca

train21

train21 32分前

$GTVH ...........also Texas state security's board ................512-305-8300
Texas has no corporate income tax so they got away with that so cant trace if they really made any money at all ?
legacystock transfer.com is also in Addison Texas CEO Denise Bogutski

shadolane

shadolane 34分前

After your comments the question is what larger organization wants Amarin? Further, on what basis would they be interested? Repurposing and oncology are still to be defined. This could take significant time to evolve.

As you suggested, civil comments are welcomed.

cottonmather

cottonmather 36分前

Steve Poplar. The world goes boom. 20 minutes https://youtu.be/ToCChF4J-e0?si=oWE-Aaq6QaExeoSb

learningcurve2020

learningcurve2020 38分前

Charlie gets it.

https://nypost.com/2026/06/06/opinion/andrew-left-faces-20-years-in-prison-but-having-a-correct-opinion-about-a-stock-shouldnt-be-a-crime/

Neurizon Therapeutics

WisdomTree Metal Securit...

Ace Global Business Acqu...

Cleantek Industries

Tiger Tasman Minerals

Nuveen Minnesota Quality...

African Discovery ()

Hsbc Usa Inc Itm Digital...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。